Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00179036 · ClinicalTrials.gov registry record
Biomagnetic Signals of Intestinal Ischemia II
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 17
- Enrollment target
NCT00179036 is a clinical trial that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 17 participants.
The verdict
NCT00179036 has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
Study Summary
The lack of blood flow to the small intestine causes mesenteric ischemia. Using a Superconducting QUantum Interference Device (SQUID) which measures the magnetic field of the small intestine, we are hoping to identify abnormalities without surgical intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2000-01 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00179036
The ClinicalTrials.gov registry entry for NCT00179036 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00179036 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00179036 about?
NCT00179036 is a clinical study titled "Biomagnetic Signals of Intestinal Ischemia II". The lack of blood flow to the small intestine causes mesenteric ischemia. Using a Superconducting QUantum Interference Device (SQUID) which measures the magnetic field of the small intestine, we are hoping to identify abnormalities without surgical intervention.
What is the current status of trial NCT00179036?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2000-01. Estimated completion is 2015-12.
Who is sponsoring clinical trial NCT00179036?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.